264 related articles for article (PubMed ID: 26497679)
1. Tristetraprolin induces cell cycle arrest in breast tumor cells through targeting AP-1/c-Jun and NF-κB pathway.
Xu L; Ning H; Gu L; Wang Q; Lu W; Peng H; Cui W; Ying B; Ross CR; Wilson GM; Wei L; Wold WS; Liu J
Oncotarget; 2015 Dec; 6(39):41679-91. PubMed ID: 26497679
[TBL] [Abstract][Full Text] [Related]
2. Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway.
Liu X; Xiao XY; Shou QY; Yan JF; Chen L; Fu HY; Wang JC
J Ethnopharmacol; 2016 Dec; 193():538-545. PubMed ID: 27686271
[TBL] [Abstract][Full Text] [Related]
3. Tristetraprolin mediates the anti-proliferative effects of metformin in breast cancer cells.
Pandiri I; Chen Y; Joe Y; Kim HJ; Park J; Chung HT; Park JW
Breast Cancer Res Treat; 2016 Feb; 156(1):57-64. PubMed ID: 26956973
[TBL] [Abstract][Full Text] [Related]
4. Tristetraprolin impairs NF-kappaB/p65 nuclear translocation.
Schichl YM; Resch U; Hofer-Warbinek R; de Martin R
J Biol Chem; 2009 Oct; 284(43):29571-81. PubMed ID: 19654331
[TBL] [Abstract][Full Text] [Related]
5. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
6. Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein.
Goddio MV; Gattelli A; Slomiansky V; Lacunza E; Gingerich T; Tocci JM; Facchinetti MM; Curino AC; LaMarre J; Abba MC; Kordon EC
Breast Cancer Res Treat; 2012 Oct; 135(3):749-58. PubMed ID: 22968621
[TBL] [Abstract][Full Text] [Related]
7. RNA-destabilizing factor tristetraprolin negatively regulates NF-kappaB signaling.
Liang J; Lei T; Song Y; Yanes N; Qi Y; Fu M
J Biol Chem; 2009 Oct; 284(43):29383-90. PubMed ID: 19738286
[TBL] [Abstract][Full Text] [Related]
8. BEX2 has a functional interplay with c-Jun/JNK and p65/RelA in breast cancer.
Naderi A; Liu J; Hughes-Davies L
Mol Cancer; 2010 May; 9():111. PubMed ID: 20482821
[TBL] [Abstract][Full Text] [Related]
9. A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients.
Griseri P; Bourcier C; Hieblot C; Essafi-Benkhadir K; Chamorey E; Touriol C; Pagès G
Hum Mol Genet; 2011 Dec; 20(23):4556-68. PubMed ID: 21875902
[TBL] [Abstract][Full Text] [Related]
10. PIM2 interacts with tristetraprolin and promotes breast cancer tumorigenesis.
Ren C; Yang T; Qiao P; Wang L; Han X; Lv S; Sun Y; Liu Z; Du Y; Yu Z
Mol Oncol; 2018 May; 12(5):690-704. PubMed ID: 29570932
[TBL] [Abstract][Full Text] [Related]
11. Induction of the RelB NF-kappaB subunit by the cytomegalovirus IE1 protein is mediated via Jun kinase and c-Jun/Fra-2 AP-1 complexes.
Wang X; Sonenshein GE
J Virol; 2005 Jan; 79(1):95-105. PubMed ID: 15596805
[TBL] [Abstract][Full Text] [Related]
12. Depletion of tristetraprolin in breast cancer cells increases interleukin-16 expression and promotes tumor infiltration with monocytes/macrophages.
Milke L; Schulz K; Weigert A; Sha W; Schmid T; Brüne B
Carcinogenesis; 2013 Apr; 34(4):850-7. PubMed ID: 23241166
[TBL] [Abstract][Full Text] [Related]
13. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
14. Both NF-κB and c-Jun/AP-1 involved in anti-β2GPI/β2GPI-induced tissue factor expression in monocytes.
Xia L; Zhou H; Hu L; Xie H; Wang T; Xu Y; Liu J; Zhang X; Yan J
Thromb Haemost; 2013 Apr; 109(4):643-51. PubMed ID: 23467542
[TBL] [Abstract][Full Text] [Related]
15. NF-kappaB mediates MPP+-induced apoptotic cell death in neuroblastoma cells SH-EP1 through JNK and c-Jun/AP-1.
Yang HJ; Wang L; Xia YY; Chang PN; Feng ZW
Neurochem Int; 2010 Jan; 56(1):128-34. PubMed ID: 19778565
[TBL] [Abstract][Full Text] [Related]
16. The RNA binding protein tristetraprolin down-regulates autophagy in lung adenocarcinoma cells.
Dong F; Li C; Wang P; Deng X; Luo Q; Tang X; Xu L
Exp Cell Res; 2018 Jun; 367(1):89-96. PubMed ID: 29577897
[TBL] [Abstract][Full Text] [Related]
17. The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors.
Shen Q; Uray IP; Li Y; Krisko TI; Strecker TE; Kim HT; Brown PH
Oncogene; 2008 Jan; 27(3):366-77. PubMed ID: 17637753
[TBL] [Abstract][Full Text] [Related]
18. Identification of an AP1-ZFP36 Regulatory Network Associated with Breast Cancer Prognosis.
Canzoneri R; Naipauer J; Stedile M; Rodriguez Peña A; Lacunza E; Gandini NA; Curino AC; Facchinetti MM; Coso OA; Kordon E; Abba MC
J Mammary Gland Biol Neoplasia; 2020 Jun; 25(2):163-172. PubMed ID: 32248342
[TBL] [Abstract][Full Text] [Related]
19. Hyperactivated NF-{kappa}B and AP-1 transcription factors promote highly accessible chromatin and constitutive transcription across the interleukin-6 gene promoter in metastatic breast cancer cells.
Ndlovu MN; Van Lint C; Van Wesemael K; Callebert P; Chalbos D; Haegeman G; Vanden Berghe W
Mol Cell Biol; 2009 Oct; 29(20):5488-504. PubMed ID: 19687301
[TBL] [Abstract][Full Text] [Related]
20. Tumour necrosis factor alpha induces co-ordinated activation of rat GSH synthetic enzymes via nuclear factor kappaB and activator protein-1.
Yang H; Magilnick N; Ou X; Lu SC
Biochem J; 2005 Oct; 391(Pt 2):399-408. PubMed ID: 16011481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
